迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300244 迪安诊断

已收盘 08-11 15:00:00

{"stockData":{"symbol":"300244","market":"SZ","secType":"STK","nameCN":"迪安诊断","latestPrice":16.06,"timestamp":1754895783000,"preClose":15.8,"halted":0,"volume":18344552,"delay":0,"changeRate":0.0165,"floatShares":501000000,"shares":625000000,"eps":-0.6424,"marketStatus":"已收盘","change":0.26,"latestTime":"08-11 15:00:00","open":15.66,"high":16.12,"low":15.66,"amount":293000000,"amplitude":0.0291,"askPrice":16.06,"askSize":87,"bidPrice":16.05,"bidSize":453,"shortable":0,"etf":0,"ttmEps":-0.6424,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754962200000},"marketStatusCode":5,"adr":0,"adjPreClose":15.8,"symbolType":"stock","openAndCloseTimeList":[[1754875800000,1754883000000],[1754888400000,1754895600000]],"highLimit":17.38,"lowLimit":14.22,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":624979436,"isCdr":false,"pbRate":1.51,"roa":"--","roe":"--","epsLYR":-0.579,"committee":-0.375489,"marketValue":10037000000,"turnoverRate":0.0366,"status":0,"floatMarketCap":8053000000},"requestUrl":"/m/hq/s/300244","defaultTab":"news","newsList":[{"id":"2557565566","title":"迪安诊断：将AI技术升级为驱动业务增长的核心引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=2557565566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557565566?lang=zh_cn&edition=full","pubTime":"2025-08-07 20:48","pubTimestamp":1754570907,"startTime":"0","endTime":"0","summary":"看到贵司在大力发展AI，并且也已经取得了一些成绩，从长远考虑，公司是否会把AI产品从医疗服务的辅助手段提升成为公司的一个新的利润增长点？公司已明确将AI产品作为公司自有产品之一，并制定了AI三年战略规划，致力于将AI技术从辅助手段升级为驱动业务增长的核心引擎，尤其在疾病风险评估、健康管理、专病辅助诊断等场景中创造新业务价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700036266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","300244","BK0070","BK0146","BK0042","BK0236","BK0114","BK0186","BK0028"],"gpt_icon":0},{"id":"2557334711","title":"肝炎概念盘中跳水，迪安诊断跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557334711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557334711?lang=zh_cn&edition=full","pubTime":"2025-08-06 13:05","pubTimestamp":1754456726,"startTime":"0","endTime":"0","summary":"08月06日，肝炎概念盘中跳水，截至13点05分，肝炎概念整体指数下跌2.02%，报1166.500点。从个股上来看，该概念的成分股中，迪安诊断跌0.43%，人福医药、圣湘生物、一品红跌幅居前。从资金上来看，截止发稿，肝炎概念概念主力净流入为-18.80亿，其中千红制药受到资金热捧，主力净流入7925.99万；拉长时间线来看，该板块近20日主力资金净流入-54.95亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806130526a6d5d0c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806130526a6d5d0c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","600079","BK0236","688289","BK0114","BK0186","BK0070","BK0146","BK0197","BK0042","300244"],"gpt_icon":0},{"id":"2552453611","title":"医疗服务行业盘中拉升，迪安诊断涨3.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552453611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552453611?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:54","pubTimestamp":1752803657,"startTime":"0","endTime":"0","summary":"07月18日，医疗服务行业盘中拉升，截至09点54分，医疗服务行业整体指数上涨0.50%，报6048.010点。从个股上来看，该行业的成分股中，迪安诊断涨3.70%，创新医疗、药明康德、金域医学涨幅居前。从资金上来看，截止发稿，医疗服务行业主力净流入为-9149.14万，其中药明康德受到资金热捧，主力净流入8544.70万；拉长时间线来看，该板块近20日主力资金净流入-20.20亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071809541797aa80c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071809541797aa80c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300244","BK0114","BK0186","BK0028","BK0284","SG9999001069.SGD","603882","BK0042","BK0236","BK0146","BK0197","BK0070"],"gpt_icon":0},{"id":"2549445583","title":"迪安诊断新注册《健康体检管理系统1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2549445583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549445583?lang=zh_cn&edition=full","pubTime":"2025-07-06 01:23","pubTimestamp":1751736190,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迪安诊断（300244）新注册了《健康体检管理系统1.0》项目的软件著作权。今年以来迪安诊断新注册软件著作权3个。结合公司2024年年报财务数据，2024年公司在研发方面投入了3.06亿元，同比减29.3%。通过天眼查大数据分析，迪安诊断技术集团股份有限公司共对外投资了43家企业，参与招投标项目27次；财产线索方面有商标信息245条，专利信息8条，著作权信息39条；此外企业还拥有行政许可36个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0042","BK0186","BK0114","300244","BK0236","BK0197","BK0070"],"gpt_icon":0},{"id":"2546761241","title":"体外诊断概念盘中拉升，迪安诊断涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546761241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546761241?lang=zh_cn&edition=full","pubTime":"2025-06-27 10:21","pubTimestamp":1750990879,"startTime":"0","endTime":"0","summary":"06月27日，体外诊断概念盘中拉升，截至10点21分，体外诊断概念整体指数上涨1.00%，报1071.050点。从个股上来看，该概念的成分股中，迪安诊断涨6.02%，安必平、金域医学2只股涨幅超过5%。从资金上来看，截止发稿，体外诊断概念概念主力净流入为2741.43万，其中乐普医疗受到资金热捧，主力净流入3448.21万；拉长时间线来看，该板块近20日主力资金净流入-31.26亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627102119a71fce1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627102119a71fce1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","BK0197","BK0236","BK0028","BK0146","BK0284","BK0114","BK0186","688393","BK0070","300244","603882","SG9999001069.SGD"],"gpt_icon":0},{"id":"2546761405","title":"辅助生殖概念盘中拉升，迪安诊断涨7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546761405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546761405?lang=zh_cn&edition=full","pubTime":"2025-06-27 10:17","pubTimestamp":1750990647,"startTime":"0","endTime":"0","summary":"06月27日，辅助生殖概念盘中拉升，截至10点17分，辅助生殖概念整体指数上涨1.00%，报486.470点。从个股上来看，该概念的成分股中，迪安诊断涨7.27%，思创医惠、贝瑞基因、*ST苏吴涨幅居前。从资金上来看，截止发稿，辅助生殖概念主力净流入为3687.42万，其中圣诺生物受到资金热捧，主力净流入2366.95万；拉长时间线来看，该板块近20日主力资金净流入-51.16亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627101727a4c01a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627101727a4c01a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","688117","600200","BK0146","BK0186","BK0197","BK0239","BK0188","300244","BK0060","BK0114","BK0070","BK0042","BK0012","BK0028"],"gpt_icon":0},{"id":"2546275471","title":"脑科学(脑机接口)概念盘中拉升，迪安诊断涨2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546275471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546275471?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:50","pubTimestamp":1750902620,"startTime":"0","endTime":"0","summary":"06月26日，脑科学(脑机接口)概念盘中拉升，截至09点50分，脑科学(脑机接口)概念整体指数上涨0.54%，报879.740点。从个股上来看，该概念的成分股中，迪安诊断涨2.54%，航天长峰、航天发展、高德红外涨幅居前。从资金上来看，截止发稿，脑科学(脑机接口)概念主力净流入为-2.17亿，其中寒武纪-U受到资金热捧，主力净流入1.99亿；拉长时间线来看，该板块近20日主力资金净流入-67.33亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626095020a4be4226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626095020a4be4226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0041","600855","BK0236","300244","BK0058","BK0010","BK0188","BK0197","BK0042","BK0114","BK0070","BK0251","BK0037","BK0146","BK0028","BK0186"],"gpt_icon":0},{"id":"2546211227","title":"6月25日辅助生殖概念上涨0.12%，板块个股迪安诊断、物产中大涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2546211227","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546211227?lang=zh_cn&edition=full","pubTime":"2025-06-25 18:51","pubTimestamp":1750848691,"startTime":"0","endTime":"0","summary":"6月25日，截至收盘，辅助生殖概念上涨0.12%，板块资金流出40827.38万。上涨个股家数33个，下跌个股家数17个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/25185151303876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0186","BK0187","BK0236","BK0196","BK0114","BK0197","BK0028","BK0042","BK0036","600704","BK0146","300244","BK0250","BK0070","BK0188","BK0012"],"gpt_icon":0},{"id":"2535716418","title":"迪安诊断涨8.27%，太平洋一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2535716418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535716418?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:29","pubTimestamp":1747124988,"startTime":"0","endTime":"0","summary":"今日迪安诊断涨8.27%，收盘报15.71元。2025年5月2日，太平洋研究员谭紫媚,李啸岩发布了对迪安诊断的研报《迪安诊断点评报告：业绩暂时承压，数智化成果逐步兑现》，该研报对迪安诊断给出“买入”评级。维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为9.41%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中泰证券的江琦。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300025135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","300244"],"gpt_icon":0},{"id":"2535798381","title":"【医疗保健板块走高 尚荣医疗、交大昂立涨停】 医疗保健板块走高，尚荣医疗涨停，交大昂立此前涨停，华大基因、安必平、迪安诊断等涨幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535798381","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535798381?lang=zh_cn&edition=full","pubTime":"2025-05-13 13:44","pubTimestamp":1747115040,"startTime":"0","endTime":"0","summary":"医疗保健板块走高，尚荣医疗涨停，交大昂立此前涨停，华大基因、安必平、迪安诊断等涨幅居前。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/13134450337579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0197","BK0077","BK0028","BK0221","BK0046","300676","BK0070","BK0236","BK0186","BK0251","300244","BK0042","BK0101","600530","BK0239","BK0146","BK0122","002551","688393","BK0196","BK0226","BK0114"],"gpt_icon":0},{"id":"2532856610","title":"太平洋：给予迪安诊断买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2532856610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532856610?lang=zh_cn&edition=full","pubTime":"2025-05-02 09:30","pubTimestamp":1746149456,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚,李啸岩近期对迪安诊断进行研究并发布了研究报告《迪安诊断点评报告：业绩暂时承压，数智化成果逐步兑现》，给予迪安诊断买入评级。诊断产品业务实现收入81.34亿元，同比下降6.36%。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为19.06。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050200001715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","300244"],"gpt_icon":0},{"id":"2531712861","title":"迪安诊断（300244）2025年一季报简析：净利润减190.66%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2531712861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531712861?lang=zh_cn&edition=full","pubTime":"2025-04-30 07:07","pubTimestamp":1745968028,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期迪安诊断发布2025年一季报。截至本报告期末，公司营业总收入23.65亿元，同比下降20.45%，归母净利润-2100.56万元，同比下降190.66%。本报告期迪安诊断公司应收账款体量较大，当期应收账款占最新年报营业总收入比达59.62%。去年的净利率为-1.39%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000009132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244"],"gpt_icon":0},{"id":"2531333252","title":"图解迪安诊断一季报：第一季度单季净利润同比减190.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531333252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531333252?lang=zh_cn&edition=full","pubTime":"2025-04-29 03:17","pubTimestamp":1745867875,"startTime":"0","endTime":"0","summary":"证券之星消息，迪安诊断2025年一季报显示，公司主营收入23.65亿元，同比下降20.45%；归母净利润-2100.56万元，同比下降190.66%；扣非净利润-2630.58万元，同比下降211.77%；负债率42.54%，投资收益-653.27万元，财务费用4278.88万元，毛利率26.39%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900001715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244"],"gpt_icon":0},{"id":"2530728131","title":"信达证券发布迪安诊断研报，业绩短期承压，检验业务呈现高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2530728131","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530728131?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:38","pubTimestamp":1745847480,"startTime":"0","endTime":"0","summary":"信达证券04月28日发布迪安诊断（300244.SZ，最新价：13.68元）研报。主要观点包括：1）收入短期承压，加大精准中心建设，检验业务呈现高质量发展；2）竞争加剧+减值影响表观利润，AI赋能，加速“数智化”转型。风险提示：市场需求提升不及预期；产品研发进度不及预期；市场竞争加剧风险。AI点评：迪安诊断近一个月获得2份券商研报关注。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821444894e5f670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821444894e5f670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","BK0042","BK0114","BK0186","601059","BK0028","BK0276","BK0197","BK0070","300244","BK0146"],"gpt_icon":0},{"id":"2529609726","title":"中国银河：给予迪安诊断买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2529609726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529609726?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:29","pubTimestamp":1745490575,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对迪安诊断进行研究并发布了研究报告《2024年年报业绩点评：大额减值致年度首亏，战略深化打开发展局面》，给予迪安诊断买入评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400033567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","601881"],"gpt_icon":0},{"id":"2529757539","title":"迪安诊断(300244.SZ)发布2024年度业绩，归母净亏损3.57亿元，同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2529757539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529757539?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:14","pubTimestamp":1745338475,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪安诊断(300244.SZ)披露2024年年度报告，报告期公司实现营收121.96亿元，同比下降9.04%;归母净利润亏损3.57亿元，同比由盈转亏;扣非净利润亏损3.8亿元，同比由盈转亏;基本每股收益-0.5790元。公司拟每10股派发现金红利2.50元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0236","BK0042","BK0114","BK0186","BK0146","BK0028","BK0197","300244","BK0070"],"gpt_icon":0},{"id":"2518436222","title":"迪安诊断：公司未参与华为发布的瑞金病理模型项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2518436222","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518436222?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:51","pubTimestamp":1741611060,"startTime":"0","endTime":"0","summary":"有投资者向迪安诊断提问， 迪安诊断与华为云正式签署了数字化诊疗全面合作协议。根据协议内容，双方将以云计算和 AI 技术为基础，携手共同打造包括医检大数据平台、AI 大模型、大数据与健康云平台等在内的一系列项目，所以2025年2月15号华为发布的瑞金病理模型参与了项目研发嘛公司回答表示，尊敬的投资者，您好！公司未参与华为发布的瑞金病理模型项目。谢谢！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-10/doc-inepetxi3403220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0028","BK0042","BK0186","BK0114","300244","BK0236","BK0197","BK0070"],"gpt_icon":0},{"id":"2518258233","title":"迪安诊断：海外实验室投入运营 自研产品拓展多国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258233","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518258233?lang=zh_cn&edition=full","pubTime":"2025-03-10 09:08","pubTimestamp":1741568904,"startTime":"0","endTime":"0","summary":"金融界3月10日消息，有投资者在互动平台向迪安诊断提问：董秘您好，想了解一下贵公司的海外业务拓展情况的介绍，谢谢！公司回答表示：公司的国际化业务迈入了“服务+产品”双轮驱动的新阶段，海外越南设立的首家第三方医学实验室已投入运营，产品渠道业务也同步启动；子公司迪安生物凭借自研产品率先开拓海外市场，其数智化病理产品已在东南亚、欧洲、中亚等多个国家和地区推广。\n\n\r\n            责任编辑：栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10090848616747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300244","BK0114","BK0186","BK0028","BK0042","BK0236","BK0146","BK0197","BK0070"],"gpt_icon":0},{"id":"2518584742","title":"迪安诊断：在肿瘤精准诊断、感染性疾病检测等领域技术领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2518584742","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518584742?lang=zh_cn&edition=full","pubTime":"2025-03-10 09:08","pubTimestamp":1741568902,"startTime":"0","endTime":"0","summary":"金融界3月10日消息，有投资者在互动平台向迪安诊断提问：尊敬的董秘你好，最近我国学者证实细胞衰老可逆转，请问公司在细胞基因领域和抗衰领域以及基因测序有哪些业务呢。请完善回答公司在以上领域的强项。公司回答表示：在细胞基因领域，公司在肿瘤精准诊断、感染性疾病检测、HPV检测方面技术领先，提供涵盖预防、筛查、诊断、治疗到康复全过程的检测服务；在抗衰领域，公司积极布局功能医学创新产品体系及整体解决方案，助力医护工作者和各类人群开展全生命周期健康管理；在基因测序领域，公司拥有宏基因组测序、靶向测序等多样技术平台，检测项目丰富，助力临床个性化精准治疗。\n\n\r\n            责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10090848616749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300244","BK0028","BK0197","BK0186","BK0114","BK0042","000973.SH","BK0146","BK0070","BK0236"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754946803682,"stockEarnings":[{"period":"1week","weight":-0.0025},{"period":"1month","weight":0.0601},{"period":"3month","weight":0.0395},{"period":"6month","weight":0.1341},{"period":"1year","weight":0.4292},{"period":"ytd","weight":0.4389}],"compareEarnings":[{"period":"1week","weight":0.0179},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0808},{"period":"6month","weight":0.09},{"period":"1year","weight":0.2744},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"迪安诊断技术集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"54498人(较上一季度增加47.09%)","perCapita":"9201股","listingDate":"2011-07-19","address":"浙江省杭州市西湖区三墩镇金蓬街329号2幢5层","registeredCapital":"62497万元","survey":"　　迪安诊断技术集团股份有限公司的主营业务是致力于为各类综合医院与专科医院、社区卫生服务中心(站)、乡(镇)卫生院、体检中心、疾病预防控制中心等各级医疗机构提供以疾病为导向的体外诊断产品及医学检测服务,以满足就医者的综合临床诊疗需求。公司的主要产品是诊断服务、渠道产品、自产产品、其他。","listedPrice":23.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪安诊断(300244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪安诊断,300244,迪安诊断股票,迪安诊断股票老虎,迪安诊断股票老虎国际,迪安诊断行情,迪安诊断股票行情,迪安诊断股价,迪安诊断股市,迪安诊断股票价格,迪安诊断股票交易,迪安诊断股票购买,迪安诊断股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪安诊断(300244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}